Antibiotic sensitivity of strains enterococcus faecalis, isolated from patients with urinary tract infections

Антибиотикочувствительность штаммов enterococcus faecalis, выделенных от больных с инфекциями мочевыводящей системы
Saltanat Eshimova 1, Zhaksygul Tulegenova 1, Nurzhamal Kenzhebayeva 1, Aigul Dinmukzamedova 2
More Detail
1 №1 city hospital of Astana, Microbiology laboratory, Astana, Kazakhstan
2 L.N. Gumilyov Eurasian national university of Astana, Department of General Biology and Genomics, Astana, Kazakhstan
J CLIN MED KAZ, Volume 4, Issue 38, pp. 46-49.
OPEN ACCESS 3060 Views 2131 Downloads
Download Full Text (PDF)


The aim of this study: Study of antibiotic susceptibility strains of Enterococcus faecalis, isolated from patients with urinary tract infections.
Methods. Isolated microorganisms were identified to species, determined their sensitivity to antimicrobial agents in accordance with the methodological guidelines and using bacteriological analyzer WalkAway (USA).
Results. The results of microbiological Studies have shown that the most effective drugs against Enterococcus faecalis is vancomycin, streptomycin Cinergy, norfloxacin, chloramphenicol.
Conclusions. The choice of antibiotic therapy until bakteriogrammy urine should be based on the data of the local microbiological monitoring, taking into account the spectrum of infectious agents and their level of antimicrobial resistance.


Eshimova S, Tulegenova Z, Kenzhebayeva N, Dinmukzamedova A. Antibiotic sensitivity of strains enterococcus faecalis, isolated from patients with urinary tract infections. Journal of Clinical Medicine of Kazakhstan. 2015;4(38):46-9.


  • Olson R.P., Harrell L.J., Kaye K.S. Antibiotic resistance in urinary isolates of Escherichia coli from college women with urinary tract infections, Antimicrob. Agents Chemother, 2009, Vol. 53, No. 3, pp. 1285– 1286.
  • Zhanel G.G., DeCorby M., Adam H. et al. Prevalence of antimicrobial- resistant pathogens in Canadian hospitals: results of the Canadian ward surveillance study (CANWARD 2008), Antimicrob. Agents Chemother, 2010, Vol. 54, No. 11, pp. 4684–4693.
  • Zhanel G.G., Hisanaga T.L., Laing N.M. et al. Antibiotic resistance in Escherichia coli outpatient urinary isolates: fi nal results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA), Int. J. Antimicrob. Agents, 2006, Vol. 27, No. 6, pp. 468–475.
  • Jacobsen S.M., Stickler D.J., Mobley H.L., Shirliff M.E. Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis, Clin. Microbiol. Rev, 2008, Vol. 21, No. 1, pp. 26–59.
  • Eshimova S.A., Tulegenova Zh.S., Kenzhebaeva N.B. et al. Etiologicheskaya struktura vozbuditeley infektsiy mochevyivodyaschih putey, Vestnik ENU, 2015, No.2, pp.164-170.
  • Prikaz Minzdrava SSSR ot 22.04.85 N535 ob unifikacii mikrobiologicheskih (bakteriologicheskih) metodov issledovaniya, primenyaemyh v kliniko-diagnosticheskih laboratoriyah lechebno-profilakticheskih uchrezhdenij. Moskva,1985, 125 p.
  • Semina N.A., Sidorenko S.V., Rezvan S.P. et al. Guidelines for Susceptibility Testing of Microorganisms to Antibacterial Agents, 2004, 92 p.
  • Fisher K, Phillips C. The ecology, epidemiology and virulence of Enterococcus. Microbiology, 2009, No. 155 (6), pp.1749– 1757.
  • Dan M, Poch F, Leibson L, Smetana S et al. Rectal colonization with vancomycin-resistant enterococci among high-risk patients in an Israeli hospital. J. Hosp. Infect, 1999, No. 43 (3), pp.231–238.
  • Bonten MJ, Slaughter S, Hayden MK, Nathan C et al. External sources of vancomycin-resistant enterococci for intensive care units. Crit. Care Med., 1998, No. 26 (12), pp. 2001–2004.
  • Marothi YA, Agnihotri H, Dubey D. Enterococcal resistance – an overview. Indian J. Med. Microbiol, 2005, No. 23 (4), pp.214–219.
  • Hidron Al, Edwards JR, Patel J, Horan TC et al. NHSH annual update antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect. Control. Hosp. Epidemiol, 2008, No. 29 (11), pp.996–1011.
  • Donabedian SM, Thal LA, Hershberger E, Perri MB et al. Molecular characterization of gentamicin-resistant enterococci in the United States evidence of spread from animals to humans through food. J. Clin. Microbiol, 2003, No. 41 (3), pp.1109–1113.
  • Drees M, Snydman DR, Schmid CH, Barefoot L et al. Prior environmental contamination increases the risk of acquisition of vancomycin-resistant enterococci. Clin. Infect Dis, 2008, No. 46 (5), pp.678–685.
  • Kafil HS, Asgharzadeh M. Vancomycin-resistant Enterococcus faecium and Enterococcus faecalis isolated from education hospital of Iran. Maedica (Buchar), 2014, No. 9(4), pp.323–327.
  • Sidler JA, Battegay M, Tschudin-Sutter S, Widmer AF et al. Enterococci, Clostridium difficile and ESBL-producing bacteria: epidemiology, clinical impact and prevention in ICU patients. Swiss Med Wkly, 2014, No. 144, pp. 9–39.
  • Batistao DW, Gontijo-Filho PP, Conceicao N, Oliveira AG et al. Risk factors for vancomycin-resistant enterococci colonization in critically ill patients. Mem. Ins. Oswaldo Cruz, 2012, No. 107 (1), pp.57–63.